Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM8 | O00222 | 1/20 | 0.60 |
| ▸ | GRM6 | O15303 | 1/20 | 0.60 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.60 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.60 |
| ▸ | GSR | P00390 | 1/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.60 |
| ▸ | GRM5 | P41594 | 1/20 | 0.60 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.60 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.60 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.60 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.60 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.60 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.60 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.60 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.60 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.60 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.60 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.60 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL709482 | 1.00 | GRM8 (0.60) | GRM8GRM6GRIN2DGRIN3BGSR | |
| Thioacetamide SCHEMBL711295 | 0.89 | DPP4 (0.50) | GRM8GRM6GRIN2DGRIN3BGSR | |
| Thioacetamide SCHEMBL711294 | 0.89 | DPP4 (0.50) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL29833669 | 0.82 | BLM (0.58) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL1534035 | 0.82 | CTSD (0.44) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL27741548 | 0.82 | GRM8 (0.60) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL564272 | 0.82 | GRM8 (0.60) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL1534041 | 0.82 | CTSD (0.44) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL288407 | 0.82 | BLM (0.58) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL11478144 | 0.82 | BLM (0.58) | GRM8GRM6GRIN2DGRIN3BGSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023124537-A1 | CONJUGATE AND ANTIBODY-DRUG CONJUGATE PREPARED USING SAME | 辽宁键凯科技有限公司 | 2023-07-06 | — | — | WO | claimed |
| US-8318503-B2 | Method for determining the amount of conjugated taxane in polyglut acid-taxane conjugates | CELL THERAPEUTICS, INC. (US) | 2012-11-27 | — | — | US | claimed |
| EP-1967854-B1 | Method for determining the amount of conjugated taxane in polyglutamic acid-taxane conjugates | CELL THERAPEUTICS EUROPE SRL (IT) | 2010-11-03 | — | — | EP | claimed |
| US-20100151582-A1 | METHOD FOR DETERMINING THE AMOUNT OF CONJUGATED TAXANE IN POLYGLUT ACID-TAXANE CONJUGATES | CELL THERAPEUTICS, INC. (US) | 2010-06-17 | — | — | US | claimed |
| WO-2008107174-A1 | METHOD FOR DETERMINING THE AMOUNT OF CONJUGATED TAXANE IN POLYGLUT ACID-TAXANE CONJUGATES | CELL THERAPEUTICS INC. (US) | 2008-09-12 | — | — | WO | claimed |
| EP-1967854-A1 | Method for determining the amount of conjugated taxane in polyglutamic acid-taxane conjugates | Cell Therapeutics Europe S.R.L. (IT) | 2008-09-10 | — | — | EP | claimed |
| US-5079155-A | Bioaffinity chromatography | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-01-07 | — | — | US | claimed |
| EP-0140556-A1 | A T-DNA derived vector | LUBRIZOL GENETICS INC. (US) | 1985-05-08 | — | — | EP | claimed |
| EP-4593882-A1 | MICROPARTICLE FORMULATIONS FOR INTRAVENOUS THERAPY AND METHODS FOR THEIR MANUFACTURE AND USE | The Methodist Hospital (US) | 2025-08-06 | — | — | EP | disclosed |
| US-12331197-B2 | Power transmission belt | DAYCO EUROPE S.R.L. (IT) | 2025-06-17 | — | — | US | disclosed |
| EP-3404056-B1 | METHOD FOR PRODUCING THERMOPLASTIC ELASTOMER COMPOSITION | ZEON CORP (JP) | 2025-06-11 | — | — | EP | disclosed |
| CN-120076831-A | Anti-ROR 1 antibodies and antibody conjugates, compositions comprising anti-ROR 1 antibodies or antibody conjugates, and methods of making and using anti-ROR 1 antibodies and antibody conjugates | 苏特罗生物制药公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-119455004-A | Compositions, methods and uses comprising antibody-TLR agonist conjugates | AMBRX公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-119455003-A | Compositions, methods and uses comprising antibody-TLR agonist conjugates | AMBRX公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-1052144-A | The Compounds and methods for of diagnosis and treatment cancer | AUSTRALIAN COMMERCIAL RESEARCH (AU) | 1991-06-12 | — | — | CN | disclosed |
| US-4950738-A | ANTICARCINOGENS | CYTOGEN CORPORATION (US) | 1990-08-21 | — | — | US | disclosed |
| WO-1988009823-A1 | AMINE DERIVATIVES OF ANTHRACYCLINE ANTIBIOTICS AND ANTIBODY CONJUGATES THEREOF | CYTOGEN CORPORATION (US) | 1988-12-15 | — | — | WO | disclosed |
| EP-0294294-A2 | Amine derivatives of anthracycline antibiotics | CYTOGEN CORPORATION (US) | 1988-12-07 | — | — | EP | disclosed |
| US-4745161-A | Soluble and biodegradable polyamino acid activated for bonding of biologically active compound | CESKOSLOVENSKA AKADEMIE VED (CS) | 1988-05-17 | — | — | US | disclosed |
| EP-0140556-A1 | A T-DNA derived vector | LUBRIZOL GENETICS INC. (US) | 1985-05-08 | — | — | EP | disclosed |